OSMR and lymphoma: Among the novel N3a-sensitive PI3K/mTOR-reducing proteins in lymphomas, were increased PHLDA3 (R_cHL/MCL), OSMR (R_cHL), COL6A3, and Rictor (P_ALCL/cHL).